FluroTech Ltd. (FLURF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3268.00 CAD | 68.87% |
| 2022 | -462.66 Thousand CAD | 86.71% |
| 2021 | -3.48 Million CAD | -319.48% |
| 2020 | -830.06 Thousand CAD | 80.28% |
| 2019 | -4.2 Million CAD | -9.28% |
| 2018 | -3.85 Million CAD | -8460.01% |
| 2017 | -45 Thousand CAD | -14.73% |
| 2016 | -39.22 Thousand CAD | 28.55% |
| 2015 | -54.89 Thousand CAD | -3.95% |
| 2014 | -52.81 Thousand CAD | 46.89% |
| 2013 | -99.44 Thousand CAD | -45.52% |
| 2012 | -68.33 Thousand CAD | 47.08% |
| 2011 | -129.13 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -233.68 Thousand CAD | 201.71% |
| 2024 Q2 | -34.53 Thousand CAD | -367.88% |
| 2023 Q4 | -33.05 Thousand CAD | 23.52% |
| 2023 Q3 | -43.21 Thousand CAD | -34.86% |
| 2023 Q2 | -32.04 Thousand CAD | 10.24% |
| 2023 FY | - CAD | 68.87% |
| 2023 Q1 | -35.7 Thousand CAD | 29.63% |
| 2022 Q1 | -251.33 Thousand CAD | 51.06% |
| 2022 Q3 | -59.61 Thousand CAD | 40.97% |
| 2022 Q2 | -100.99 Thousand CAD | 59.82% |
| 2022 FY | - CAD | 86.71% |
| 2022 Q4 | -50.73 Thousand CAD | 14.9% |
| 2021 FY | - CAD | -319.48% |
| 2021 Q3 | -1.12 Million CAD | -3.38% |
| 2021 Q4 | -513.59 Thousand CAD | 54.35% |
| 2021 Q1 | -754.8 Thousand CAD | -208.79% |
| 2021 Q2 | -1.08 Million CAD | -44.19% |
| 2020 Q3 | -279.63 Thousand CAD | 44.41% |
| 2020 Q4 | 693.82 Thousand CAD | 348.12% |
| 2020 Q1 | -943.52 Thousand CAD | 23.4% |
| 2020 FY | - CAD | 80.28% |
| 2020 Q2 | -503.03 Thousand CAD | 46.69% |
| 2019 Q3 | -840.97 Thousand CAD | 35.99% |
| 2019 FY | - CAD | -9.28% |
| 2019 Q1 | -823.04 Thousand CAD | 35.17% |
| 2019 Q2 | -1.31 Million CAD | -59.62% |
| 2019 Q4 | -1.23 Million CAD | -46.47% |
| 2018 Q1 | -11.22 Thousand CAD | 18.91% |
| 2018 Q4 | -1.26 Million CAD | 16.91% |
| 2018 Q3 | -1.52 Million CAD | -307.28% |
| 2018 Q2 | -375.13 Thousand CAD | -3242.54% |
| 2018 FY | - CAD | -8460.01% |
| 2017 Q1 | -6758.00 CAD | 51.6% |
| 2017 FY | - CAD | -14.73% |
| 2017 Q4 | -13.84 Thousand CAD | -52.05% |
| 2017 Q3 | -9103.00 CAD | 40.5% |
| 2017 Q2 | -15.3 Thousand CAD | -126.4% |
| 2016 Q2 | -10.06 Thousand CAD | -22.77% |
| 2016 Q3 | -6997.00 CAD | 30.49% |
| 2016 Q4 | -13.96 Thousand CAD | -99.56% |
| 2016 FY | - CAD | 28.55% |
| 2016 Q1 | -8199.00 CAD | 59.06% |
| 2015 Q4 | -20.02 Thousand CAD | -139.9% |
| 2015 Q3 | -8349.00 CAD | -12.52% |
| 2015 Q2 | -7420.00 CAD | 61.15% |
| 2015 FY | - CAD | -3.95% |
| 2015 Q1 | -19.1 Thousand CAD | -99.31% |
| 2014 Q4 | -9583.00 CAD | 0.59% |
| 2014 Q1 | -14.27 Thousand CAD | 1.86% |
| 2014 FY | - CAD | 46.89% |
| 2014 Q2 | -19.31 Thousand CAD | -35.34% |
| 2014 Q3 | -9640.00 CAD | 50.09% |
| 2013 FY | - CAD | -45.52% |
| 2013 Q1 | -26.77 Thousand CAD | 40.28% |
| 2013 Q2 | -7160.00 CAD | 73.25% |
| 2013 Q3 | -50.96 Thousand CAD | -611.86% |
| 2013 Q4 | -14.54 Thousand CAD | 71.47% |
| 2012 Q4 | -44.82 Thousand CAD | -241.67% |
| 2012 Q1 | -5268.00 CAD | 94.1% |
| 2012 FY | - CAD | 47.08% |
| 2012 Q3 | -13.12 Thousand CAD | -156.2% |
| 2012 Q2 | -5121.00 CAD | 2.79% |
| 2011 Q4 | -89.29 Thousand CAD | -1534.86% |
| 2011 Q1 | -92.34 Thousand CAD | 0.0% |
| 2011 Q2 | -15.03 Thousand CAD | 83.72% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q3 | -5462.00 CAD | 63.67% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.56 Million USD | 100.008% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.281% |
| Össur hf. | 137.38 Million USD | 99.998% |
| QHSLab, Inc. | -91.29 Thousand USD | 103.58% |
| Wellstar International, Inc. | -1.35 Million USD | 100.241% |
| Össur hf. | 137.38 Million USD | 99.998% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -58.46 Thousand USD | 105.59% |
| Aurora Spine Corporation | -454.37 Thousand USD | 100.719% |
| BrainsWay Ltd. | -2.31 Million USD | 100.141% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 101.191% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 99.941% |
| Vivos Inc. | -2.79 Million USD | 100.117% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 101.653% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 100.196% |
| Zecotek Photonics Inc. | -3.44 Million USD | 100.095% |
| Avitar, Inc. | -1.66 Million USD | 100.196% |
| Nanomix Corporation | -8.13 Million USD | 100.04% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 99.967% |
| Theraclion SA | -2.05 Million USD | 100.159% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.45 Million USD | 100.225% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 100.19% |
| Lombard Medical, Inc. | -28.06 Million USD | 100.012% |
| ALR Technologies Inc. | -6.4 Million USD | 100.051% |
| Stratec SE | 39.91 Million USD | 99.992% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 96.763% |
| Heart Tronics, Inc. | -14.85 Million USD | 100.022% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.001% |
| VMS Rehab Systems, Inc. | -68.55 USD | 4867.323% |
| NewCardio, Inc. | -9.37 Million USD | 100.035% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 100.105% |
| Ingen Technologies, Inc. | -8639.00 USD | 137.828% |
| Odyssey Group International, Inc. | -2.13 Million USD | 100.153% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.862% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 100.462% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 100.036% |
| IR-Med Inc. | -4.89 Million USD | 100.067% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.025% |
| Polarean Imaging plc | -11.19 Million USD | 100.029% |
| United American Healthcare Corporation | -59 Thousand USD | 105.539% |
| ECGI Holdings, Inc. | -2.99 Million USD | 100.109% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 102.763% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 100.519% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 100.636% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 99.283% |
| Urologix, Inc. | -6.34 Million USD | 100.052% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 100.264% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 100.427% |
| SS Innovations International, Inc. | -20.37 Million USD | 100.016% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 101.467% |
| Smith & Nephew plc | 1 Billion USD | 100.0% |
| NIOX Group Plc | 11.07 Million USD | 99.97% |
| Fuse Medical, Inc. | 1.83 Million USD | 99.822% |
| Broncus Holding Corporation | -25.19 Million USD | 100.013% |
| Brain Scientific Inc. | -7.93 Million USD | 100.041% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 100.035% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 117.761% |